Compounds > aripiprazole

Page last updated: 2024-08-24

aripiprazole and Parkinsonian Disorders

aripiprazole has been researched along with Parkinsonian Disorders in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (69.23)	29.6817
2010's	3 (23.08)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Espay, AJ; Gupta, HV; Sharma, VD	1
Jimenez-Solem, E; Jørgensen, A; Rasmussen, HB; Thorleifsson, A; Werge, T	1
Chen, MH; Liou, YJ	1
Endo, T; Miyake, N; Miyamoto, S; Ogino, S; Yamaguchi, N	1
Germain, C; Pasquier de Franclieu, S; Petitjean, F	1
Babu, GN; Chandra, P; Kumar, R; Saddichha, S	1
Kim, TS; Lee, C; Pae, CU; Paik, IH	2
Sharma, A; Sorrell, JH	1
Ali, IM; Morris, HR; Wickremaratchi, M	1
Chen, YY; Hung, GC	1
Constant, EL; Emmanuel, H; Hermans, E; Jean-Jean, A; Koener, B; Maloteaux, JM	1
Dorado, P; Llerena, A; López-Torres, E; Peñas-Lledó, E; Salomón, J; Vicario, F	1

Other Studies

13 other study(ies) available for aripiprazole and Parkinsonian Disorders

Article	Year
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia. Tremor and other hyperkinetic movements (New York, N.Y.), 2020, 12-16, Volume: 10 Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; Drug Substitution; GABA Modulators; Humans; Male; Parkinsonian Disorders; Pelvis; Propranolol; Quinolones; Serotonin Agents; Tardive Dyskinesia; Tetrabenazine; Thiophenes; Treatment Failure; Valine	2020
Severe Parkinsonism and Creatine Kinase Increase After Low-Dose Aripiprazole Treatment in a Patient of African Descent. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Black People; Creatine Kinase; Humans; Male; Middle Aged; Parkinsonian Disorders; Psychoses, Substance-Induced	2017
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones	2013
Successful treatment of delusional disorder with low-dose aripiprazole. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia, Paranoid; Treatment Outcome	2008
[Aripiprazole induced Parkinsonism: A case report]. L'Encephale, 2009, Volume: 35, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia, Paranoid	2009
Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient. Journal of clinical pharmacology, 2012, Volume: 52, Issue:9 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depression; Dystonia; Female; Fluoxetine; Humans; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones	2012
Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication. The Journal of neuropsychiatry and clinical neurosciences, 2005,Fall, Volume: 17, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbon Monoxide Poisoning; Female; Humans; Mental Disorders; Parkinsonian Disorders; Piperazines; Quinolones	2005
Aripiprazole-induced parkinsonism. International clinical psychopharmacology, 2006, Volume: 21, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Male; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones	2006
Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication. The Journal of neuropsychiatry and clinical neurosciences, 2006,Winter, Volume: 18, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Carbon Monoxide Poisoning; Female; Humans; Parkinsonian Disorders; Piperazines; Psychoses, Substance-Induced; Quinolones; Treatment Outcome	2006
Aripiprazole associated with severe exacerbation of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones	2006
Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient. Pharmacopsychiatry, 2007, Volume: 40, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Male; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia	2007
Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole. The American journal of psychiatry, 2007, Volume: 164, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Receptors, Dopamine D2	2007
Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:3 Topics: Adolescent; Alleles; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinsonian Disorders; Piperazines; Polymorphism, Genetic; Psychotic Disorders; Quinolones; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risk Factors	2008